• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    VTV Therapeutics, M42 Submit Cadisegliatin Phase 2 Protocol in US

    GLOBENEWSWIRE

    USPTO Allows vTv Therapeutics` Cadisegliatin Patent

    GLOBENEWSWIRE

    vTv Therapeutics Reinitiates Screening in CATT1 Phase 3 Trial

    GLOBENEWSWIRE

    vTv Therapeutics: FDA Lifts Clinical Hold on Cadisegliatin Program

    GLOBENEWSWIRE

    vTv Announces FDA Submission for First Phase 3 Study of Cadisegliatin

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.